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Eyes on the Prize: Lessons from the Cholera Wars for Modern Scientists,
Physicians, and Public Health Officials†
Edward T. Ryan*
Harvard University, Massachusetts General Hospital, Boston, Massachusetts
PROLOGUE
On October 19, 2010, a cholera outbreak was reported in the
Artibonite area of Haiti, 10 months after a devastating earth-
quake had struck the island. Three weeks later on November
6, 2010, then American Society of Tropical Medicine and
Hygiene President Edward T. Ryan, MD, gave the following
Presidential Address at the American Society of Tropical Med-
icineand Hygiene AnnualMeeting inAtlanta, Georgia.
The American Society of Tropical Medicine and Hygiene
traces its origins to 1903, a time when health professions were
organizing to address new health threats, including those
posed by growing international exchanges and evolving colo-
nialism.Oneofthesethreatswascholera,aseveredehydrating
illness caused by Vibrio cholerae, but we meet here 107 years
laterwithournewspapersfilledyetagainwithnewsof cholera,
this time in Haiti. In October 2010, after a devastating earth-
quake and displacement of millions of persons in Haiti, a large
andspreadingoutbreakofcholerabeganthatshowsnosignsof
abating. We know a great deal about cholera, but as we gather
here tonight, we must acknowledge that we as a species are
literally still plagued by it. What lessons can we as scientists,
physicians, and health officers garner from the story of chol-
era’s impact on humanity, and perhaps more importantly,
humanity’s responsesto cholera?
I will also preface my Address with the caveat that I am not a
historian and that any errors, omissions, or mis-attributions are
my fault. They represent my best knowledge after spending the
last two decades working on cholera, and I welcome revisions
and corrections. As you will see, the story of cholera is both
horrifying and rich, with historical details that are extraordinary.
Cholera is caused by a flagellated gram-negative bacterium,
Vibrio cholerae. Two serogroups of V. cholerae (of approxi-
mately 200) are associated with epidemic cholera: V. cholerae
O1 and O139. The pathogen contains two circular chromo-
somes that have been sequenced, and much is known about
its fundamental microbiology. Vibrio cholerae exists as a free-
living water-based organism, usually in brackish coastal
waterways, and often in association with chitin-shelled organ-
isms and zooplankton. With the right temperature and nutri-
ent profile, V. cholerae can also exist inland in fresh water,
a reality that underpins many of the more recent cholera out-
breaks in Africa and now Haiti. Historically, the main eco-
logic niche of V. cholerae was probably the top of the Bay of
Bengal, where salt and fresh water mix in a large delta system
fed by the great eastern rivers of southern Asia.
Although V. cholerae may have existed and caused human
disease from antiquity, the first relatively well-documented
written records that describe what was probably a cholera
outbreak date from the 1500s. Gaspar Correia, a Portuguese
explorer, described in the Lendas da India in 1543 an out-
break among army troops in Calicut and Goa to which 20,000
deaths were ascribed. He noted that the “disease (was charac-
terized) by vomiting with drought of water accompanying it as
if the stomach were parched up and cramps that force the
sinews of the joints, disease sudden-like which struck with pain
in the belly so that a man did not last out 8 hours of time”.
The more modern historical record, however, begins at a
time when European colonialism and economic and military
exchanges reached sustained engagement in the upper
reaches of the Bay of Bengal. Since then, medical historians
have declared seven global cholera pandemics. The first pan-
demic started in 1817 among British troops in what was then
Fort William, Calcutta. The disease spread out across India,
down through Southeast Asia and across to central Asia, and
reached as far as Egypt and the shores of the Caspian Sea
before receding. The second pandemic began in 1827, also
in the Ganges delta area, and spread across Asia, up through
Europe and across Germany to the port city of Hamburg.
From there it jumped to England and spread throughout the
United Kingdom. It reached France, and was carried by ship
to Quebec for its first introduction to the New World, spread-
ing down the Hudson Valley to New York City and then
throughout the eastern, southern, and western United States.
In 1832, the pandemic entered Australia, and by 1833 had
reached Latin America and the Caribbean, probably largely
imported from Spain and Portugal to its colonies. This second
pandemic receded by 1837 and was the first truly modern
global pandemic, affecting all inhabited continents. Despite
that, responses to the spread of cholera at this stage were
largely local in nature and not particularly effective.
The third pandemic began in 1839 among British troops in
Afghanistan and this pandemic spread similarly to the second
pandemic, receding only by 1855. However, the third pan-
demic was associated with a number of major developments.
One development concerned the nature of how humans and
health professionals perceived the cause of disease and illness.
At this point in history, a prevailing concept of disease causa-
tion in Western medicine was that of miasma. Miasma (liter-
ally from the Greek word for pollution or defilement) initially
ascribed disease to unhealthy smells and emanations from
decaying matter, but miasmaticism grew to incorporate a
wider range of root foulness, including socioeconomic status
and moral fiber. A primary tool to fight miasma was hygiene,
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model of disease origin at the time, and definitely the minor-
ity camp in the 1830s–1850s before the revolutionary work of
Pasteur and Koch and the other great founders of microbiol-
ogy, was the growing field of contagiousness. It was on this
background that John Snow first encountered, pondered, and
analyzed cholera, and moved the contagiousness concept of
disease into its ascendancy.
Although John Snow is best known now for his work on
cholera, during his lifetime he was mostly renowned as an
anesthesiologist; he was the personal anesthetist to Queen
Victoriaduringdeliveryofanumberofherchildren.Although
these two aspects might seem unrelated, they are actually
intimately linked. Within a year of the description of the pub-
lic successful use of ether at the Massachusetts General
Hospital in Boston in October 1846, Snow in England had
experimented extensively with ether and published a seminal
work On the Inhalation of Vapour Ether in Surgical Opera-
tions, rapidly becoming a recognized expert in the new field.
John Snow’s background in gases, ether, chloroform, their
gaseous distribution, and their effects on the human body
directly informed his view of cholera. He reasoned that gas-
eous emanations from rotting debris and unclean conditions
could not explain the spread of cholera, nor cholera itself, an
illness he had personal experience with having served alone
as a medical apprentice in a small rural English town during
the 1831 outbreak.
By 1849, soon after his work on ether, he published his first
work on cholera On the Mode of Communication of Cholera,
suggesting water as a transmission source of a causative (but
unseen) agent. This work was not well received at the time
(the devastating and personal reviews in the Lancet make for
interesting and sobering reading when seen in the context of
time). During the third pandemic, Snow continued this chol-
era work, but focused his response to his critics with data,
not conjecture. The core of this response was what he referred
to as his Grand Experiment in which he worked with William
Farr, the chief biostatistician for London and a pioneer bio-
statistician, analyzing data from 1848 and 1849 describing
cholera-related deaths in London. In this analysis, Snow
compared the cholera death burden among London inhabi-
tants who received their water from the Southwark and
Vauxhall Water Company, which drew its water downstream
of London (after the city’s sewage had been added and closer
to the Thames River meeting the open sea [i.e., higher salin-
ity]), to the death rate among persons who received their
water from the Lambeth Waterworks Company, which drew
its water upstream of London. Snow found that the death
rate from cholera was 315 deaths/10,000 persons of London
for those who received their water from Southwark and
Vauxhall, but only 37 deaths/10,000 persons for those who
received their water from the Lambeth Company.
Snow was about to publish his analysis when another large
cholera outbreak occurred in the Soho area of London on
the night of August 31, 1854. This outbreak occurred a few
days after a five-month-old baby named Sarah Lewis had
died from cholera on Broad Street. On the night of August
31, hundreds of persons became sick in Soho with almost
200 deaths within 24 hours, mostly centering on Broad Street.
Snow lived close to Broad Street and personally investigated
the distribution of deaths and cases. He recognized that the
largest concentration of cases seemed to associate with use
of the water pump at Broad Street, and he petitioned the
St. James Parish Council to disconnect the handle on the
Broad Street pump. Not really believing Snow, but seeing
little downside, the Council agreed. In reality, the outbreak
was coming to an end by the time this action was taken, but it
should be noted that Sarah Lewis’ father became sick with
cholera on the day that the pump handle was removed, and
the contamination of the water source would have started
anew because the draining cesspool from the Broad Street
house of the Lewis family had broken down and was in com-
munication underground with the Broad Street pump. John
Snow’s intervention, therefore, probably prevented a second
large outbreak of cholera in Soho.
With his larger Grand Experiment supplemented by the
data from the Broad Street outbreak, Snow republished his
work in 1855. This time the data were more convincing, were
confirmed by subsequent enquiries, and more persons began
to recognize the importance of Snow’s work. The implications
were significant, and facilitated the movement away from
considering cholera as being related to inhalation and gases,
to being considered the first recognized water-borne illness.
Quite simply, miasmaticism had been dealt a deadly blow,
and the contagiousness theory of disease took hold. Snow’s
work is normally considered the birth of evidence and field-
based epidemiology, and pointed the way toward practical
prevention of disease transmission.
Of note, during this third pandemic in 1854, Filippo Pacini, a
clinician and scientist in Florence, Italy, dealing with that city’s
large outbreak, used microscopy to identify a curved bacillus in
the stool of cholera victims, naming the organism Vibrio
cholerae because it appeared to vibrate under the microscope.
Pacini’s illustrations leave little doubt that he had visualized the
correct organism. However, his work was largely ignored.
The fourth pandemic began in 1863 and in a particularly
grim chapter of this pandemic, cholera killed one-third of the
90,000 Mecca pilgrims attending Hajj that year. The infection
then spread through Africa, Europe, Latin America, and the
United States before receding in 1870. This pandemic marked
the ascendancy of the contagiousness theory of disease, and
specifically of the water-borne theory relating to cholera.
During this pandemic, policy, public health, and engineering
interventions were being implemented in countries with the
resources to prevent cholera deaths.
The fifth pandemic began in 1881 and is referred to as the
Steam and Suez pandemic, spreading from India through
Egypt through Africa and Europe, as well as to China and
Japan. During this pandemic, Robert Koch did his pioneering
work in Egypt and then Calcutta in 1883 and 1884, in which
he isolated the cholera organism (which he first called
Kommabazillen [comma shaped bacillus]). In recognition of
Pacini’s precedence, the organism was subsequently renamed
back to Pacini’s Vibrio cholerae. Of note, London averted an
outbreak during this pandemic largely through the presence
of its new sewer system that had been completed in 1875 by
Joseph Bazalgette. New York similarly averted an outbreak
in 1892 by implementing quarantine in the New York harbor
and using the first laboratory-based public health interven-
tion. Specifically, the U.S. National Institutes of Health and
Centers for Disease Control and Prevention trace their roots
to the predecessor of the U.S. Public Health Service, the
Marine Health Service that was formed in 1798 and originally
chartered to provideforthe medical careof merchant seamen.
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Service with examining passengers arriving with infectious
diseases, especially cholera, yellow fever, and tuberculosis. In
1887, Joseph Kinyoun had set up a one-room laboratory in the
Marine Hospital on Staten Island, New York. He was trained
in microbiology and used a new Zeiss microscope to diagnose
cholera cases based on the work of Koch. This development
represented the first laboratory confirmation of cases at a
public health level, and enabled targeted quarantining of
ships and prevention of outbreaks. The fifth pandemic, there-
fore, showed large advances in microbiology and germ theory
with the isolation of the causative agent, as well as develop-
ment of diagnostic and public health screening protocols. It
also represented the first division of the haves and the have
nots in the global population. Previous to this time, all persons
were equally susceptible to cholera. Now cholera began to be
associated with poverty and global social disparity.
The sixth pandemic was prolonged, and stretched from
1899 to 1923, involving Asia, Africa and Europe, but sparing
the Western Hemisphere. During the Mecca pilgrimage in
1902, another large outbreak among Hajj pilgrims occurred,
and repetitive outbreaks among Mecca pilgrims resulted in
the enforcement of strict quarantines. It was at the El Tor
Quarantine Camp in the Sinai that El Tor V. cholerae, a new
biotype, was first identified in 1905.
In 1961, in what is today modern Sulawesi–Indonesia, the
seventh pandemic began with El Tor V. cholerae re-emerging,
and subsequently spanning out in repetitive waves across the
globe. By 1970, cholera had extended into Africa and Europe,
and by 1991 was introduced into Latin America. It is sobering
to note that in the 1970s cholera reappeared in Europe after a
hiatus of at least 50 years, causing 30 deaths in Naples, Italy,
and more than 2,000 cases in Lisbon, Portugal. Cholera was
reintroduced into Africa in 1970, spreading across the continent.
It has taken brutal hold in many areas of Africa, becoming
endemic in many water systems, and now recurrently plagues
that continent. A particularly gruesome outbreak occurred in
Goma,Zairein1994inwhich50,000personsdiedwithina21-day
period from a concomitant cholera and shigellosis outbreak.
Cholera has played major roles in many advances of modern
science and public health, perhaps noting more firsts than any
other pathogen (Table 1). For instance, I have already men-
tioned that V. cholerae was the first causative agent that was
identified by microscopy. Cholera also led to the first use of
intravenous fluid to treat an ill human. In 1830, Jaehnichen
injected six ounces of water intravenously into a cholera
patient; the patient improved but then died two hours later.
Also in 1830, the German surgeon J. F. Dieffenbach injected
whole blood into three cholera patients and once again,
although improvement was noted, they died shortly thereafter.
During 1831–1832, a prescient W.B. O’Shaughnessy noted that
thepurposeoftreatmentshouldbe“torestorespecificgravity
of blood and replace deficient saline matter” in the blood of
cholera patients, prompting Thomas Latta in Scotland to use
intravenous fluid replacement therapy with water and salt.
Of note, 5 of 15 patients who were in the end stage of disease
survived,a report that wassufficient to bepublishedin 1832.
Despite this relative success, intravenous fluid therapy
was largely ignored until 1908 and 1909 when Leonard Rogers
in Calcutta established sterility and protocol techniques, and
showed that sufficient volume replacement with intravenous
fluid could reduce mortality rates from 70% to 30%. Intrave-
nous fluid, therefore, became standard treatment at this point.
In 1910, Andrew Sellards described acidosis in cholera
patients, suggesting that the use of alkali might be of benefit.
Once Rogers added alkali to his regimen, mortality rates
decreased further from 30% to 20%. During 1958–1964,
Phillips, Watten, Carpenter, Gordon, and others measured
the exact loss of water and electrolytes in cholera patients,
prompting the development of specific intravenous fluid
with isotonic saline and alkali. These researchers found that
administering this fluid plus oral water could reduce the chol-
era case-fatality rate to < 1%.
During 1902–1963, physiologists had been examining
sodium and glucose transport and their interaction in the
intestine, prompting Robert A. Phillips, a U.S. military physi-
cian, to question whether the sodium-glucose water–coupled
system may be intact during cholera. In 1962, he initiated a
trial in the Philippines in which patients received oral solution
with glucose that was added for its nutritional value. The
addition of glucose led to water absorption and positive fluid
and sodium balance, but unfortunately, 5 of 30 patients died,
possibly from hypernatremia because the sodium concentra-
tion in the solution was high. Because deaths occurred, the
protocol was deemed as less efficient than intravenous fluid
treatment and was not pursued as practical. Pierce in Calcutta
and Hirschhorn in Dhaka continued to use isotonic oral
hydration with glucose and sodium in equal concentrations,
noting that it decreased the use of intravenous fluid. Nalin,
Cash, and others also recognized that oral cholera treatment
needed to be tailored to the individual amount of dehydra-
tion and ongoing losses, work that was facilitated by the use
of a cholera cot (first invented by Watten in Bangkok in
1959) in which fluids passed by an afflicted patient channel
down a central hole in a rubber cot into a bucket, facilitating
measurement of fluid losses and estimation of required
Table 1
Cholera milestones: driven by evidence
First modern global pandemic
Arguably the pathogen that can kill the most number of humans in
the shortest period of time
Response to cholera led to major changes in public health and
development of governmental and international health boards and
agencies
Driver of evidence-based epidemiology
Driver of end of miasmaticism
First described water-borne (non-airborne/contact) illness
First pathogen identified by microscopy (Pacini, Florence, 1854)
First use of laboratory-based public health intervention
Led to discovery of lipopolysaccharide (heat-stable toxin)
Led to the discovery of complement system
First serological basis of diagnosis (vibriocidal and agglutination
assays)
Led to development of serotyping of bacteria (agglutination assay)
First enterotoxin identified (cholera toxin) and biochemical
mechanism of action determined
First enterotoxin sequenced
First whole-organism analysis of bacterial pathogen gene and protein
expression profiling directly in humans
First large field use/trial of laboratory-derived vaccine (Ferran, Spain,
1884; Haffkine, Simpson, India, 1893–1894)
First effective oral vaccine (Sawtschenko and Sabolotny, 1893)
First randomized control group vaccine field trial (Besredka oral
bilivaccine vs parenteral, 1920s, India and China)
First use of therapeutic intravenous fluid (Jaehnichen and Hermann,
1830)
Driver of development of oral rehydration solution (ORS)
612 RYANreplacement therapy. These investigator and colleagues in
Dhaka noted that using the new protocol of oral fluid replace-
ment decreased intravenous fluid need by 80% in severely
dehydrated adult cholera patients, a result that was published in
the Lancet in 1968.
In 1971 during the Bangladesh War of Independence,
there was large displacement of refugees, and cholera broke
out in refugee camps and showed a case-fatality rate of 30%.
With limited resources and scant access to intravenous fluids
and supplies, health providers used oral rehydration solution
(ORS), demonstrating a shockingly low mortality rate of 3%
under such adverse conditions. This prompted BRAC, a
Bangladesh non-government organization, and the Bangladeshi
Ministry of Health through its Oral Rehydration Treatment
Program, to expand the use of ORS, teaching rural families
how to make and use simple home-based ORS. This roll
out was facilitated by the work of researchers and clinicians
at the International Centre for Diarrhoeal Disease Research
in Bangladesh (ICDDR,B), who played critical roles in devel-
oping quality control mechanisms for home-based ORS, and
conducting clinical trials. It is estimated that ORS has directly
saved 40 million lives since its introduction.
Cholera, therefore, has driven many milestones by evi-
dence-based approaches. Cholera was a plague; it was the
pandemic that defined much of 19th century life, and it was
associated with the global economy and emerging urbaniza-
tion, presaging influenza and polio. It also played large
roles in the field of public health, including being the illness
upon which epidemiology was founded, detailed transmis-
sion was documented, steps to interrupt transmission were
implemented, and cases could be diagnosed. It also played a
major role in the development of public health policies and
public health organizations, and the development of sani-
tary procedures and techniques. For instance, in 1851 in
Paris, the International Sanitary Conferences began with
cholera being the main focus. These meetings eventually
led by 1907 to the first international health organization,
the Office of International Hygiene, which was also based
in Paris and was replaced by the Health Organization of the
League of Nations, and eventually by the World Health
Organization (WHO). It was also a cholera outbreak in
Egypt that prompted the first meeting of the World Health
Assembly in 1948.
A number of cholera specific issues remain. It is discon-
certing that ORS use is not optimal and decreasing in many
locations, pointing out that increased education and com-
munication at the household level are required. It is also
disconcerting that cholera cots are not more widely used.
The ongoing outbreaks of cholera among the most impov-
erished persons in the world also highlight some of our
failures as a global society. Although the long-term solution
to prevent cholera is safe water and improved sanitation,
WHO currently estimates that 800 million persons globally
lack safe water and 2.6 billion persons lack adequate sanita-
tion. It will therefore be decades, if not longer, before these
injustices are rectified, and as such, the use of cholera vac-
cines in disease control and prevention, especially in the
50 countries in which cholera is endemic, needs to be pro-
moted and evaluated.
So what are the lessons for cholera for us here tonight?
First, the cholera wars include fascinating stories of scientific
and evidence-based investigation in basic science, physiology,
toxicology, microbiology, environmental sciences, immunol-
ogy, vaccinology, clinical field trials, epidemiology, health
delivery, evaluation, and public health and policy responses.
Perhaps the most important lesson in cholera and what I term
the eyes on the prize is the development of ORS. Oral rehy-
dration solution is based on science, costs a few pennies, can
be made and used by the illiterate, and has saved millions of
lives. It requires no special interventions and is as simple as
drinking. It is the most practical, cost-effective health inter-
vention driven by basic science yet developed, and it repre-
sents the paradigm of the interface of basic science, clinical
medicine, and public health.
However, we should take a step back and look at addi-
tional lessons from the cholera story. The first lesson is that
basic life scientists need to interface with applied science
and not operate in a disconnected vacuum, however pure and
beautiful that sphere may be. It was applied/translational
scientists who took 80 years of wondrous basic science
advancements and developed a rational evidence-based
intervention that has saved millions of lives. In turn, applied
scientists and clinicians need to recognize that they practice
in a paradigmatic system and although they can use such
systems as constructs to approach patients, they need to
enable evidence to dictate their responses. This practice will
require fluency with advances in basic science and the abil-
ity to question current practice, constantly looking for ways
to improve. Public health officials need to reject settling for
current policies just because they are good enough. Why are
oral cholera vaccines not being more widely used and
improved cholera vaccines not being more aggressively pur-
sued? Public health officials will be required to use practical
judicious balancing (but accelerated balancing) of what is
working versus what would be better.
We as a Society also can garner a number of lessons.
Tropical medicine was forged in an earlier wave of globali-
zation, one that grew in part out of imperialism, colonialism,
and military intervention. Our diseases always reflect our
reality, and cholera is no exception; it was the first global
pandemic that was able to capture this new ecologic niche.
We are now in a different stage of globalization, one of
economic interchange and rapidity of travel on a backdrop
of urbanization and mega-cities. Although tropical diseases
still affect a large portion of the globe, the traditional tropi-
cal diseases now largely affect persons who are being left
behind by globalization. We need to continue to serve these
persons, but we also need to recognize that they and we are
facing new challenges. These challenges include emerging
infectious diseases, largely viral and zoonotic in nature,
often transmitted by the respiratory route or by vectors. We
need to not only address these, but also recognize that
severe weather and climate change may change the rules of
engagement relating to these emerging infections (and other
health issues), and that we need to be flexible and innovative
in our responses.
At present, we as a Society are making major contribu-
tions in vector biology and arbovirology, but we are not
addressing the large global burden of respiratory infections,
which currently kill more children than any other category
of disease. A second challenge is diseases related to delivery
and infrastructure systems. In 2008, the global human popu-
lation, for the first time in history, largely resided in cities,
often in informal settlement areas in resource-limited set-
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settlements means that our current infrastructure systems
canactuallyworsenmanyhealthsituationsandactasefficient
vehicles for disease transmission. This finding is especially
true for food-borne and water-borne diseases, and we as a
Society need to continue to address these important aspects
that lead to intestinal infections that are the second leading
killerofchildrenglobally.Thethirdgeneralareaconcernsthe
non-communicable diseases that are increasingly afflicting
the human population, including those associated with the
use of tobacco and obesity, as well as diabetes, hypertension,
andcardiovascularandoncologicconditions.AsaSociety,we
do not do a good job in addressing these new global pan-
demics. How will we respond to our globalization health
threats? Our strength has historically been in generating
scientific knowledge on communicable diseases, and this
knowledge has been used to support informed and evidence-
based decision making for more than a century. A question
for us tonight, however, 107 years into the history of our
impressive Society, is will we build upon this base. A century
from now, will it be said that we as a Society also responded
to our global health threats, both ancient and new?
In closing, I would like to say what an honor it has been
serving you as President this past year, and God willing, I look
forward to working with you going forward.
EPILOGUE
Fromitsonsetin2010until2013,thecholeraoutbreakinHaiti
has thus far affected more than 600,000 persons, resulting in
more than 8,000 deaths. New cholera cases occur daily. The
Haitian outbreak is now the largest in recorded history. Since
the outbreak, a more affordable oral killed cholera vaccine has
received WHO pre-qualification, and studies are evaluating its
use in Haiti and elsewhere, although no large-scale use has yet
occurred.TheWHOhasalsoformedacholeravaccinestockpile
for possible use in future outbreaks. The quest for the best long-
term solutions of safe water and adequate sanitation for the
people of Haiti and other resource-limited areas continues, with
substantial actions having been taken by national governments,
international agencies, and their partners since 2010. Much has
been accomplished in the last 36 months; much remains to be
done. As we move forward locally and globally, we will all need
tokeep oureyes ontheprize.
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